Chemoinformaics analysis of Paeonidin-3-O-Beta-D-Glucoside
| Molecular Weight | 461.399 | nRot | 5 |
| Heavy Atom Molecular Weight | 440.231 | nRig | 24 |
| Exact Molecular Weight | 461.109 | nRing | 4 |
| Solubility: LogS | -3.957 | nHRing | 2 |
| Solubility: LogP | 0.179 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 1 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 16 |
| nHA | 11 | APOL | 59.5647 |
| nHD | 5 | BPOL | 29.7473 |
| QED | 0.301 |
| Synth | 4.116 |
| Natural Product Likeliness | 1.695 |
| NR-PPAR-gamma | 0.92 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.961 |
| HIA | 0.788 |
| CACO-2 | -5.99 |
| MDCK | 0.0000407 |
| BBB | 0.191 |
| PPB | 0.794359 |
| VDSS | 0.792 |
| FU | 0.150956 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.08 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.219 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.265 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.038 |
| CL | 5.72 |
| T12 | 0.559 |
| hERG | 0.016 |
| Ames | 0.727 |
| ROA | 0.043 |
| SkinSen | 0.02 |
| Carcinogencity | 0.161 |
| EI | 0.01 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.876 |
| Antiviral | Yes |
| Prediction | 0.839617 |